EuroUS Ventures
Overview
EuroUS Ventures invests in companies which have passed the significant early stage hurdles of product development and just before market acceptance has been attained. They co-invest with top European investment firms, family offices and private individuals. They invest in European Venture Backed companies that want to enter the US market. They provide experienced guidance in new market development, venture partners with strong operational backgrounds, access to senior management talent to help develop US operations, resources of a large business network for partnership opportunities and an early focus on exit strategy.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Lyncean Technologies, Inc. | May 2018 | Series B | Co-investor |
| Lydus Medical | May 2021 | Seed | Co-investor |
| USound | Aug 2023 | Growth Equity | - |
| Distalmotion | Apr 2023 | Series F | - |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is EuroUS Ventures based?
EuroUS Ventures is headquartered in Switzerland.
When was EuroUS Ventures founded?
EuroUS Ventures was founded in 2005.
How many portfolio companies does EuroUS Ventures have?
EuroUS Ventures has 4 portfolio companies in Caplight's dataset.
What are some companies in EuroUS Ventures's portfolio?
Portfolio companies visible on Caplight include Lyncean Technologies, Inc., Lydus Medical, USound, Distalmotion.
What was EuroUS Ventures's most recent investment shown here?
EuroUS Ventures's most recent investment in this portfolio sample was in USound in 2023.
What sectors does EuroUS Ventures focus on?
EuroUS Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech, Healthcare & Life Sciences, Consumer & Commerce, Frontier & Industrial Tech.
What company stages does EuroUS Ventures focus on?
EuroUS Ventures typically invests at the Late stage.
What is EuroUS Ventures's AUM?
EuroUS Ventures's assets under management are estimated between $0.0 and $50.0M.